Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: A randomised controlled trial in British general practice

BMC Public Health

Volumn 8, Issue , 2008, Pages

  Park, Paul ^a   Simmons, Rebecca K ^b   Prevost, A Toby ^a   Griffin, Simon J ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CAPILLARY BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMOTION; FEASIBILITY STUDY; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PERCEPTION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCREENING; SELF CONCEPT; SPIELBERG STATE ANXIETY INVENTORY; UNITED KINGDOM; GLUCOSE BLOOD LEVEL; HEALTH CARE QUALITY; HEALTH STATUS; MASS SCREENING; MIDDLE AGED; PATIENT ATTITUDE; PATIENT PARTICIPATION; PILOT STUDY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RISK FACTOR; STATISTICS;

ADULT; AGED; ANXIETY; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FAMILY PRACTICE; FEASIBILITY STUDIES; FEMALE; GREAT BRITAIN; HEALTH STATUS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PARTICIPATION; PILOT PROJECTS; PROGRAM EVALUATION; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; RISK FACTORS;

EID: 53949086488     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-8-350     Document Type: Article

References (29)

1. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. S Wild G Roglic A Green R Sicree H King, Diabetes Care 2004 27 5 1047 1053 10.2337/diacare.27.5.1047 15111519
2. What determines the cost-effectiveness of diabetes screening? C Glumer M Yuyun S Griffin D Farewell D Spiegelhalter AL Kinmonth NJ Wareham, Diabetologia 2006 49 7 1536 1544 10.1007/s00125-006-0248-x 16752172
3. Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. NJ Wareham SJ Griffin, Bmj 2001 322 7292 986 988 11312236 10.1136/bmj.322.7292.986
4. Observations on the value of mass indiscriminate screening for diabetes mellitus based on a five-year follow-up. SM Genuth HB Houser JR Carter Jr IR Merkatz JW Price OP Schumacher RG Wieland, Diabetes 1978 27 4 377 383 640241
5. Finding diabetics-a method of screening in general practice. SP Bullimore C Keyworth, Br J Gen Pract 1997 47 419 371 374 9231472
6. Adverse effects of screening for gestational diabetes: a prospective cohort study in Toronto, Canada. D Kerbel R Glazier S Holzapfel M Yeung S Lofsky, J Med Screen 1997 4 3 128 132 9368868
7. Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: The Hoorn Screening Study. MC Adriaanse JM Dekker AM Spijkerman JW Twisk G Nijpels HM van der Ploeg RJ Heine FJ Snoek, Qual Life Res 2005 14 6 1501 1509 10.1007/s11136-004-0028-3 16110930
8. The psychological impact of screening for type 2 diabetes. MC Adriaanse FJ Snoek, Diabetes Metab Res Rev 2006 22 1 20 25 10.1002/dmrr.590 16142814
9. Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. HC Eborall SJ Griffin AT Prevost AL Kinmonth DP French S Sutton, Bmj 2007 335 7618 486 17761995 10.1136/bmj.39303.723449.55
10. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. T Lauritzen S Griffin K Borch-Johnsen NJ Wareham BH Wolffenbuttel G Rutten, Int J Obes Relat Metab Disord 2000 24 Suppl 3 S6 11 11063279
11. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. SJ Griffin PS Little CN Hales AL Kinmonth NJ Wareham, Diabetes Metab Res Rev 2000 16 3 164 171 10.1002/1520-7560(200005/06)16:3<164::AID- DMRR103>3.0.CO;2-R 10867715
12. The framing of decisions and the psychology of choice. A Tversky D Kahneman, Science 1981 211 4481 453 458 10.1126/science.7455683 7455683
13. Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. G Puavilai S Chanprasertyotin A Sriphrapradaeng, Diabetes Res Clin Pract 1999 44 1 21 26 10.1016/S0168-8227(99) 00008-X 10414936
14. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). TM Marteau H Bekker, Br J Clin Psychol 1992 31 Pt 3 301 306 1393159
15. A description and analysis of the operation and validity of the psychological stress evaluator. DH VanDercar J Greaner NS Hibler CD Spielberger S Bloch, J Forensic Sci 1980 25 1 174 188 7391775
16. The illness perception questionnaire: a new method of assessing the cognitive representation of illess. J Weinman KJ Petrie R Moss-Morris R Horne, Psychology & Health 1996 11 431 445 10.1080/08870449608400270
17. The revised illness perception questionnaire (IPQ-R). R Moss-Morris J Weinman KJ Petrie R Horne LD Cameron D Buick, Psychology & Health 2002 17 1 16 10.1080/08870440290001494
18. Illness perceptions and distress in women at increased risk fo cancer. G Rees A Fry A Cull S Sutton, Psychology & Health 2004 19 6 749 765 10.1080/08870440412331279764
19. Illness perceptions: a new paradigm for psychosomatics? J Weinman KJ Petrie, J Psychosom Res 1997 42 2 113 116 10.1016/S0022-3999(96)00294-2 9076639
20. Illness representations and coping with health threats. H Leventhal DR Nerenz DJ Steele, Handbook of Psychology and Health, Social Psychological Aspects of Health Hillsdale, NJ: Erlbaum, Baum A, Taylor SE, Singer JE, 1984 IV 219 252
21. Characteristics of the healthy worker effect. J Baillargeon, Occupational medicine (Philadelphia, Pa) 2001 16 2 359 366 11319057
22. Healthy volunteer effect in industrial workers. P Froom S Melamed E Kristal-Boneh J Benbassat J Ribak, J Clin Epidemiol 1999 52 8 731 735 10.1016/S0895-4356(99)00070-0 10465317
23. Psychological impact of predicting individuals' risks of illness: a systematic review. C Shaw K Abrams TM Marteau, Soc Sci Med 1999 49 12 1571 1598 10.1016/S0277-9536(99)00244-0 10574231
24. No symptoms, no problem? Patients' understandings of non-insulin dependent diabetes. E Murphy AL Kinmonth, Fam Pract 1995 12 2 184 192 10.1093/fampra/12.2.184 7589943
25. Type 2 diabetes and depressive symptoms in older adults: a population-based study. LA Palinkas E Barrett-Connor DL Wingard, Diabet Med 1991 8 6 532 539 1832352
26. Levels and risks of depression and anxiety symptomatology among diabetic adults. M Peyrot RR Rubin, Diabetes Care 1997 20 4 585 590 10.2337/diacare.20.4. 585 9096984
27. Health Survey for England 1994. W Dong B Hedges F Lampe A Taylor, London: HMSO, Colhoun H, Prescott-Clarke P, 1996
28. Short-term Variability in Measures of Glycemia and Implications for the Classification of Diabetes. E Selvin CM Crainiceanu FL Brancati J Coresh, Arch Intern Med 2007 167 1545 1551 10.1001/archinte.167.14.1545 17646610
29. In a randomized trial, outcomes were not affected by intensive follow-up over 1 year. AJ Farmer HA Doll, J Clin Epidemiol 2005 58 10 991 996 10.1016/j.jclinepi.2005.02.016 16168344